On ECHEMI
Home > Drugs > Hepatitis coinfection
Hepatitis coinfection
Dual or multiple infection means that the same viral hepatitis patient may be infected with two or more different types of hepatitis viruses. There are currently five known types of hepatitis viruses, and there is no cross-immunity between them. That is, after being infected with one type of hepatitis virus, one can still be infected with other types of hepatitis viruses. According to the time of infection, it can be divided into simultaneous infection (mixed infection) and overlapping infection (subsequent infection).
  • Site of disease:

    liver
  • Infectious :

    Contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Abnormal liver function loss of appetite liver disease appearance liver disease face anorexia
  • Concurrent disease:

Related Drugs
Coenzyme Q10 capsules
Indication: This product is used as an adjuvant treatment for the following diseases: 1. Cardiovascular diseases, such as viral myocarditis and chronic heart failure. 2. Hepatitis, such as viral hepatitis, subacute liver necrosis and chronic active hepatitis. 3. Comprehensive treatment of cancer: it can reduce certain adverse reactions caused by radiotherapy and chemotherapy.
Manufacturer:

Jiangsu Zetai Pharmaceutical Co., Ltd.

Inosine Capsules
Indication: Used as adjuvant treatment for acute and chronic hepatitis.
Manufacturer:

Shanxi Taiyuan Pharmaceutical Co., Ltd.

Matrine Glucose Injection
Indication: Used to restore alanine aminotransferase and bilirubin to normal in patients with chronic hepatitis.
Manufacturer:

Heilongjiang Yudi Pharmaceutical Co., Ltd.

Matrine Glucose Injection
Indication: Used for elevated transaminase and abnormal bilirubin in chronic hepatitis B.
Manufacturer:

Cisen Pharmaceutical Co., Ltd.

Diammonium Glycyrrhizinate Capsules
Indication: This product is suitable for the treatment of acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase.
Manufacturer:

CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.